Ardelyx Inc (ARDX)
4.965
+0.26
(+5.41%)
USD |
NASDAQ |
Nov 15, 16:00
4.965
0.00 (0.00%)
After-Hours: 18:27
Ardelyx Cash and Short Term Investments (Quarterly): 190.40M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 190.40M |
| June 30, 2024 | 185.96M |
| March 31, 2024 | 202.58M |
| December 31, 2023 | 184.30M |
| September 30, 2023 | 165.08M |
| June 30, 2023 | 127.58M |
| March 31, 2023 | 130.37M |
| December 31, 2022 | 123.91M |
| September 30, 2022 | 90.62M |
| June 30, 2022 | 81.01M |
| March 31, 2022 | 89.70M |
| December 31, 2021 | 116.69M |
| September 30, 2021 | 141.65M |
| June 30, 2021 | 171.81M |
| March 31, 2021 | 178.21M |
| December 31, 2020 | 186.48M |
| September 30, 2020 | 185.50M |
| June 30, 2020 | 204.84M |
| March 31, 2020 | 223.21M |
| December 31, 2019 | 247.51M |
| September 30, 2019 | 103.54M |
| June 30, 2019 | 123.94M |
| Date | Value |
|---|---|
| March 31, 2019 | 151.56M |
| December 31, 2018 | 168.09M |
| September 30, 2018 | 186.41M |
| June 30, 2018 | 212.73M |
| March 31, 2018 | 127.45M |
| December 31, 2017 | 133.98M |
| September 30, 2017 | 129.29M |
| June 30, 2017 | 148.72M |
| March 31, 2017 | 173.42M |
| December 31, 2016 | 200.82M |
| September 30, 2016 | 230.09M |
| June 30, 2016 | 146.67M |
| March 31, 2016 | 171.68M |
| December 31, 2015 | 107.00M |
| September 30, 2015 | 129.05M |
| June 30, 2015 | 141.53M |
| March 31, 2015 | 98.32M |
| December 31, 2014 | 107.29M |
| September 30, 2014 | 112.04M |
| June 30, 2014 | 117.81M |
| March 31, 2014 | 33.22M |
| December 31, 2013 | 34.44M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
81.01M
Minimum
Jun 2022
247.51M
Maximum
Dec 2019
161.37M
Average
175.01M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Verve Therapeutics Inc | 539.92M |
| United Therapeutics Corp | 3.326B |
| Zoetis Inc | 1.71B |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |